Novavax

6 Stories

RFK Jr. Pick Wipes Billions Off the Value of Vaccine Firms

Companies including Pfizer, Moderna dropped sharply after Trump announcement

(Newser) - Thursday was a good day for Robert F. Kennedy Jr. and a bad day for companies that make vaccines. As President-elect Trump announced that Kennedy will be his nominee to lead the Department of Health and Human Services, stocks in top vaccine makers dropped sharply, wiping billions of dollars off...

Updated COVID Shots to Be Available in Days
New COVID Shots Are Coming
Aug 22, 2024 3:44 PM CDT

New COVID Shots Are Coming

FDA clears vaccines, and Pfizer and Moderna are ready to ship

(Newser) - Federal regulators approved updated COVID-19 vaccines on Thursday, shots designed to more closely target recent virus strains—and ideally whatever variants cause trouble this winter, too. With the Food and Drug Administration's clearance, Pfizer and Moderna are set to begin shipping millions of doses, which should be available in...

US Could Soon Have a 4th COVID Vaccine Option
FDA Clears 4th
COVID Vaccine Option
UPDATED
Jul 13, 2022 5:15 PM CDT

FDA Clears 4th COVID Vaccine Option

Novavax shot has been approved for adults

(Newser) - Update: The US is getting another COVID-19 vaccine choice. The Food and Drug Administration on Wednesday cleared Novavax shots for adults. Novavax makes a more traditional type of shot than the three other COVID-19 vaccines available for use in the US and the company hopes the protein-based vaccine will become...

Now, a 4th Vaccine Sees Strong Efficacy

Novavax says its vaccine has 90.4% overall efficacy, with 100% at preventing severe disease

(Newser) - More good news on the COVID vaccine front: A fourth company now has a strong candidate for availability in the US. Per the New York Times , the Novavax vaccine has shown an overall efficacy of 90.4% during a phase 3 trial in the US and Mexico, with 100% efficacy...

There's a New Vaccine Contender
There's a New
Vaccine Contender
the rundown
Jan 29, 2021 6:26 AM CST

There's a New Vaccine Contender

Novavax's COVID-19 vaccine appears 89% effective based on early study results

(Newser) - Novavax Inc. said Thursday that its COVID-19 vaccine appears 89% effective based on early findings from a British study and that it also seems to work—though not as well—against new mutated versions of the virus circulating in that country and South Africa. The announcement comes amid worry about...

New Vaccine Candidate Is Getting High Praise

One from Novavax 'is the first one I’m looking at and saying, ‘Yeah, I’d take that,' says virologist

(Newser) - Another coronavirus vaccine candidate is advancing in clinical trials, and the New York Times coverage about it carries this notable quote from a virologist: "This is the first one I’m looking at and saying, 'Yeah, I’d take that." The quote is from John Moore of...

6 Stories
Most Read on Newser